Bone re-growth using a sample of the patients own blood
PRGF® (Plasma rich in growth factors) is a biomedical technology developed by BTI (Biotechnology Institute) aimed at stimulating tissue regeneration through the concentration and application of growth factors and other proteins present in blood plasma.
Through the plasma rich in growth factors technology, from a minimum amount of blood from the patient the proteins responsible for the repair and regeneration of tissues can be isolated and concentrated in order to use them therapeutically. The application of this kind of plasma stimulates and accelerates the recovery of injured tissues.
Growth factors are a group of proteins present in the plasma and in the platelets in our blood that play an essential role in the processes of repair and regeneration of tissues, since they trigger biological effects such as cell proliferation and differentiation, generation of blood vessels (angiogenesis) and the migration of cells to the places where regeneration is necessary (chemotaxis). Growth factors can be regarded as the messages the body uses to tell cells when they need to grow, differentiate or move to repair an injury.
Obtaining plasma rich in growth factors is simple: it is just a case of extracting a small volume of blood from the patient and putting it through a centrifugation process to separate the different plasma fractions. This allows us to select the fraction that contains the appropriate proportion of growth factors and also to avoid the elements that might negatively interfere with the repair process.
Endoret® (prgf®) was initially developed to be applied in oral and maxillofacial surgery, becoming an international reference and revolutionising the sector. It is used in Oral surgery, Dermatology, Locomotor system, Ophtalmology
The advantages that this technology brings to this field of medicine are the following:
Endoret® (prgf®) technology can be used in daily clinical practice in: